オーストラリア - 英語 - Department of Health (Therapeutic Goods Administration)

baxter healthcare pty ltd - water for injections, quantity: 1000 ml - injection, solution - excipient ingredients: water for injections - sterilised water for injections is employed as a vehicle for medicinal products when water is a suitable solvent for dissolving or diluting injectable therapeutic substances for parenteral administration.

オーストラリア - 英語 - Department of Health (Therapeutic Goods Administration)

baxter healthcare pty ltd - sodium chloride, quantity: 8.6 g/l; calcium chloride dihydrate, quantity: 330 mg/l; potassium chloride, quantity: 300 mg/l - injection, intravenous infusion - excipient ingredients: sodium hydroxide; water for injections; hydrochloric acid - for restoring the loss of water and electrolytes as required by the clinical condition of the patient.

オーストラリア - 英語 - Department of Health (Therapeutic Goods Administration)

baxter healthcare pty ltd - heparin sodium, quantity: 2000 iu/l - injection, solution - excipient ingredients: water for injections; sodium chloride; citric acid monohydrate; dibasic sodium phosphate dodecahydrate - indications as at 11 july 2003: heparin sodium in 0.9% sodium chloride intravenous infusion is indicated as an anticoagulant in extracorporeal circulation, dialysis procedures, and as an aid in the maintenance of catheter patency.

オーストラリア - 英語 - Department of Health (Therapeutic Goods Administration)

baxter healthcare pty ltd - heparin sodium, quantity: 1000 iu/l - injection, solution - excipient ingredients: sodium chloride; citric acid monohydrate; dibasic sodium phosphate dodecahydrate; water for injections - indications as at 11 july 2003: heparin sodium in 0.9% sodium chloride intravenous infusion is indicated as an anticoagulant in extracorporeal circulation, dialysis procedures, and as an aid in the maintenance of catheter patency.

オーストラリア - 英語 - Department of Health (Therapeutic Goods Administration)

baxter healthcare pty ltd - glucose, quantity: 50 g/l; sodium chloride, quantity: 6 g/l; sodium lactate, quantity: 3.22 g/l; potassium chloride, quantity: 400 mg/l; calcium chloride dihydrate, quantity: 270 mg/l - injection, solution - excipient ingredients: water for injections - compound sodium lactate solution and 5% glucose is indicated as a source of water and electrolytes. it is also used in patients as a source of bicarbonate in the treatment of mild to moderate metabolic acidosis associated with dehydration or associated with potassium deficiency. these solutions are indicated as methods of intravenous drug delivery, if the drugs are compatible with the solutions.

シンガポール - 英語 - HSA (Health Sciences Authority)

baxter healthcare (asia) pte ltd - general hospital - this device is indicated for use in the treatment of patients with renal failure to provide pd fluid exchanges with baxter homechoice pd systems in clinical and home use settings.

シンガポール - 英語 - HSA (Health Sciences Authority)

baxter healthcare (asia) pte ltd - general hospital - the solution administration set will be used to administer fluids to a patient's vascular system from a container through a needle or catheter inserted into a vein. the proposed solution set will be primarily used to administer solutions containing the chemotherapeutic drug paclitaxel and also used for general solution administration with baxter flo-gard and colleague volumetric infusion pumps.

パナマ - 英語 - Ministerio de Salud (Dirección Nacional de Farmacia Y Drogas)

baxter oncology gmbh - mesna - mesna....400.0 mg

パナマ - 英語 - Ministerio de Salud (Dirección Nacional de Farmacia Y Drogas)

baxter oncology gmbh - ifosfamida - ifosfamida....1 g

パナマ - 英語 - Ministerio de Salud (Dirección Nacional de Farmacia Y Drogas)

baxter oncology gmbh - ciclofosfamida - ciclofosfamida....500 mg